Empresa Pesquera Eperva S.A.

—

What it is

Inversiones Nutravalor S.A. was born as Empresa Pesquera Eperva S.A. in Arica in 1956, starting with a fishmeal plant and five fishing vessels, and carried out production directly until 1999. In April 2021 it changed its name to Inversiones Nutravalor, to better reflect its current structure as a holding and investment company.

Since a restructuring in 1999, the company became a parent holding — it owns roughly 47% of Corpesca S.A., which actually runs the fishing boats, plants, and fish-processing assets. Beyond Corpesca, it also holds 13.2% of Orizon S.A., 10% of corporate-services firm SerCor S.A., 5% of Sigma S.A., and 24.5% of Comunicaciones y Ediciones Limitada.

Corpesca itself is Chile’s leading fishing company, with commercial and production operations at an international scale. The Eperva/Nutravalor entity is essentially the listed shell through which the Angelini group holds its piece of that operation.

—

Who owns it

The largest shareholder is Inversiones Angelini y Compañía Limitada — the private vehicle of one of Chile’s most powerful industrial families. Insiders collectively hold 86.1% of the shares (EODHD data), with institutional investors at 3.3%, leaving a public free float of barely 10%.

Anacleto Angelini and Gino Fabbri founded Pesquera Eperva in 1956, and the family’s grip has never loosened. The Angelini family’s control extends well beyond fishing, reaching major energy and forestry conglomerates through AntarChile and Empresas Copec.

The near-total insider ownership means the stock barely trades; minority shareholders have little influence.

—

Who runs it

The general manager (Gerente General) is Claudio Elgueta Vera. A CFO is not disclosed in available sources for this holding entity.

Roberto Angelini — the family’s current standard-bearer — chairs Corpesca and Pesquera Iquique-Guanaye, and sits on the Eperva/Nutravalor board alongside Jorge Andueza Fouque. The board is, in practice, an interlocking directorate shared across the wider Angelini industrial empire.

—

The money, in plain words

Sales of roughly CLP 347 billion (≈ US$377.6 million, TTM) flow mainly through Corpesca’s operations, consolidated upward. But the company loses money at the bottom line — it keeps minus 1.5 cents from every peso of revenue, a net margin of –1.53% — and for every peso of owners’ equity, it is currently destroying rather than creating value, a return on equity of –2.27%.

The three-year income record tells the story clearly: the company earned a thin profit only in 2018, when revenue hit CLP 411.5 billion (≈ US$447.7M, our calculation); by 2019 and 2020, as revenue fell 14% from that peak (our calculation), operating losses widened and net losses appeared. Cash on the 2020 balance sheet stood at CLP 45.4 billion (≈ US$49.4M, our calculation), with no short-term or long-term debt reported — so the balance sheet is not stressed, even as the income statement is weak.

The company pays no dividend. With losses running and 86% of shares locked in family hands, capital returns to outside shareholders are not on the table.

—

What it is doing now

The 2021 name change to Inversiones Nutravalor was intended to signal the company’s future direction — toward a broader nutrition and protein investment identity rather than a pure fishing label. Beyond fishmeal and fish oil, the group now sells protein foods, canned and frozen horse mackerel, hake, reineta, and tuna products.

No major acquisition, disposal, or leadership change has been disclosed publicly since the name change. The most recent publicly recorded transaction between the group companies dates to a 2017 secondary share deal with Corpesca (PitchBook data).

The company’s strategic moves are made quietly, inside an opaque family holding structure.

—

What to watch

• Corpesca’s catch quotas. Chile’s northern anchovy quota — set annually by regulators — is the single biggest driver of revenue and margins. Any cut squeezes the whole chain.
• Return to profitability. Three years of net losses or near-breakeven results raise the question of whether the holding structure is still earning its keep. A sustained improvement in fishmeal prices or a cost reduction at Corpesca would be the trigger.
• The name-change strategy. Whether “Nutravalor” becomes a genuine pivot toward higher-value nutrition products — or remains a rebrand on the same fishing base — will shape the long-term investment case.
• Liquidity risk. With insiders holding 86% and zero analyst coverage, the stock can move sharply on very little volume; any forced seller among minority holders faces a thin market.

—

This is news, not investment advice.